GPX4 and cervical cancer: Additionally, the study of Zhang et al.14 demonstrated that PIN1 silencing in cervical cancer cells decreases the stability and activity of NRF2, thereby downregulation of Glutathione Peroxidase 4 (GPX4), resulting in increased cellular susceptibility to cisplatin-induced oxidative stress, ferroptosis, and apoptosis.